Federal grant · project grant (b)
Metadx: Rapid Diagnosis of Fungal, Bacterial, and Viral Infections Using Whole Metagenomic Sequencing - Project Summary Invasive Fungal Infections (IFIS) Represent a Serious Health Risk to Patients Due to Their Difficult Diagnosis, Limited Treatment Options, and High Mortality Rates. Current Methods of Diagnosing Fungal Infections Are Slow and Difficult to Implement, Resulting in Many Such Infections Going Undiagnosed and Becoming Systemic Before They Can Be Effectively Treated. in Particular, the Symptoms of an Ifi Are Difficult to Distinguish From a Bacterial Infection, So Fungi Often Are Not Tested for Until Bacteria Have Been Ruled Out, Further Delaying Diagnosis. Meanwhile, Antifungal Resistance (AFR) Continues to Spread, Making Treatment Increasingly Difficult When There Are Only Four Classes of Antifungal Drugs. Rapid, Simultaneous Identification of All Pathogenic Species and Characterization of Their Drug Resistance Profiles Is Sorely Needed to Allow Efficient Diagnosis and Effective, Targeted Treatment. Such a System Would Directly Improve Patient Outcomes, While Also Decreasing the Need for Broad-spectrum Treatments That Can Lead to Increased Drug Resistance. This Project Proposes to Develop Metadx, a Groundbreaking Software Solution Leveraging Whole Metagenomic Sequencing (WMS), Bioinformatics, and Machine Learning to Diagnose Invasive Fungal Infections and Predict Antifungal Resistance in a Single Test Within 24 Hours or Less. Unlike Traditional Diagnostics That Isolate and Analyze Individual Organisms Over Days or Weeks, WMS Simultaneously and Rapidly Sequences Dna From All Organisms in a Sample. This Comprehensive Approach Can Identify All Potential Pathogens, Including Fungi, Bacteria, and Viruses, Without Requiring Separate Tests. the Proposed Work Capitalizes on Advancements in Next-generation Sequencing Technologies, Particularly Long-read Nanopore Sequencing, Which Offers Rapid Turnaround Times and Real-time Data Analysis Capabilities, Enabling the Production of Clinically Relevant Results Within Hours. Phase I of This Project Is Dedicated to Demonstrating the Feasibility of Utilizing Nanopore Sequencing for the Rapid Characterization of Fungal Infections. the Proposed Work Will Extend Parabon’s Existing Software Tools for the Analysis of Nanopore Metagenomic Sequencing Data, Currently Used for the Identification of Bacteria and Viruses and the Prediction of Antibiotic Resistance, to Include the Identification of Fungal Species and Known Antifungal Resistance Variants, as Well as Build Novel Machine Learning Models for Prediction of Afr. Upon Successful Completion of This Project, Healthcare Providers Will Have Access to a Groundbreaking Capability to Protect Patients From Amputation and Death Due to Undiagnosed or Late-diagnosed Fungal Infections.
Committed
$295,294
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.